A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Rosuvastatin (Crestor)

Rosuvastatin lowers LDL cholesterol and triglycerides to reduce cardiovascular risk.

First FDA approval2016-07-19
Generic availableYes · 18 mfrs
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one

$716.1M in CY2024 Part D spend47.9M claims · 16.3M beneficiaries · 329 plans surveyed

Lowest NADAC
$0.035/unit
20 NDCs benchmarked, lowest of all strengths.
Average NADAC
$0.035
Across all dosage forms in distribution.
Highest NADAC
$0.035
Range is tight.
Plans with PA
0 / 329
Zero PA friction — switching is purely formulary.

Questions a plan sponsor actually asks.

FAQPage schema12 entries indexed · 4 visible
What is Rosuvastatin used for?

Rosuvastatin lowers LDL cholesterol and triglycerides to reduce cardiovascular risk.

Is there a generic for Rosuvastatin?

Yes. 72 ANDAs filed at FDA, 18 generic manufacturers currently shipping.

How much does my plan pay for Rosuvastatin?

Across 329 Part D plans, Rosuvastatin averages $0.035/unit (NADAC). Lowest available: $0.035/unit. Highest in distribution: $0.035/unit.

Is Rosuvastatin on the FDA shortage list?

No. Rosuvastatin is not currently on the FDA Drug Shortage Database.

8 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Same class. Different math.

HMG-CoA Reductase Inhibitor5 alternatives in D1
01
Atorvastatin
Brand: Lipitor
$0.025Lowest NADAC
22Generic mfrs
$1.20BCY24 Part D spend
Compare →
02
Ezetimibe and Simvastatin
Brand: VYTORIN
$0.318Lowest NADAC
4Generic mfrs
CY24 Part D spend
Compare →
03
Lovastatin
HMG-CoA Reductase Inhibitor
$0.038Lowest NADAC
7Generic mfrs
$38.5MCY24 Part D spend
Compare →
04
Pitavastatin
Brand: Livalo
$1.16Lowest NADAC
8Generic mfrs
$182.6MCY24 Part D spend
Compare →
05
Simvastatin
Brand: ZOCOR
$0.028Lowest NADAC
11Generic mfrs
$190.2MCY24 Part D spend
Compare →

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (20 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.